Safelife Pharma Speciality Private Limited, a active private limited company, was established on 31 May 2016 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2016PTC281825. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Girish Sanktha Prasad Mishra (Director), Shubha Girish Mishra (Director), Sandeep Sankatha Mishra (Director). Past directors included Hemlata Laxminarayan Bhutda, Smita Mukund Bilolikar, Shilpesh Shantilal Dharod. It holds ₹4.54 Cr open charges and ₹4.90 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gala No 8, Survey No 164, Cts No 39Pt,Khindipada,Duck Line,Bhandup, West, Mumbai, Maharashtra, 400078.
U74999MH2016PTC281825
281825
31 May 2016
₹5.00 M
₹5.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Safelife Pharma Speciality Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girish Sanktha Prasad Mishra | Director | 03 Mar 2018 | Current |
| Shubha Girish Mishra | Director | 03 Mar 2018 | Current |
| Sandeep Sankatha Mishra | Director | 03 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2016 | Past |
| Pramod Abcsdd | Director | 05 Mar 2018 | Past |
| Pramod Abcsdd | Director | 01 Feb 2017 | Past |
| Pramod Abcsdd | Director | 05 Feb 2017 | Past |
| Pramod Abcsdd | Director | 05 Mar 2018 | Past |
| Pramod Abcsdd | Additional Director | 18 Oct 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Safelife Pharma Speciality Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.68% decrease. The company also saw a slight improvement in profitability, with a 7.38% increase in profit. The company's net worth Soared by an impressive increase of 158.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Safelife Pharma Speciality's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹45,382,000.00
₹4,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2022 | Others | ₹0.38 M | Open |
| 25 Sep 2018 | Others | ₹4.50 Cr | Open |
| 01 Sep 2020 | Others | ₹3.20 M | Satisfied |
| 17 Aug 2020 | Others | ₹1.70 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Safelife Pharma Speciality, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Safelife Pharma Speciality, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Safelife Pharma Speciality's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 01 Sep 2020 via Charge ID 100377816 with Others was fully satisfied on 31 Dec 2024. was recorded as a recent event.
A charge registered on 17 Aug 2020 via Charge ID 100377815 with Others was fully satisfied on 31 Dec 2024. was recorded as a recent event.
Progress on A charge with Others of Rs. 0.38 M registered on 09 May 2022 with Charge ID 100575822 was modified on 27 Dec 2024. was documented.
A charge with Others of Rs. 45.00 M registered on 25 Sep 2018 with Charge ID 100209735 was modified on 27 Dec 2024. was recorded as a recent event.
Safelife Pharma Speciality Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Safelife Pharma Speciality Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The CIN of Safelife Pharma Speciality Private Limited is U74999MH2016PTC281825.
Safelife Pharma Speciality Private Limited is headquartered at Gala No 8, Survey No 164, Cts No 39Pt,Khindipada,Duck Line,Bhandup, West, Mumbai, Maharashtra, 400078.
Safelife Pharma Speciality Private Limited was incorporated on 31 May 2016.
The current directors of Safelife Pharma Speciality Private Limited are
The primary industry of Safelife Pharma Speciality Private Limited is Trade.
Safelife Pharma Speciality Private Limited is unlisted.
The authorized capital of Safelife Pharma Speciality Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Safelife Pharma Speciality Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX